Diretrizes para Submissão de Amostras
A Complete Organoid Study, Built Around Your Question
Bring us the biological objective and the material or data you already have. We build the project around the comparison you need, bringing model work, experimental conditions, sequencing, and analysis into the same plan.
- From tissue to molecular results: we assess model feasibility, identify relevant characterization, and plan material for the experiments and sequencing that follow.
- From established organoids to an experimental answer: we connect your culture history and model assessment with the required perturbations, molecular readouts, and comparisons.
- From existing data to further interpretation: we review the study design, files, and metadata to define feasible reanalysis or integration, without repeating completed work unnecessarily.
Our organoid sequencing services provide a molecular-analysis component within this broader project approach. The research plan can address tumor biology, normal epithelial tissue, or developmental questions, with model suitability evaluated for the intended use.
For example, a study of compound responses in patient-derived tumor organoids can connect model characterization, exposure conditions, response measurements, and RNA profiling. Planning these together establishes which samples and time points need to correspond, so molecular findings can be interpreted alongside the experiment rather than in isolation.
Connected Organoid Services Within One Research Plan
The services below are capabilities we bring together to deliver your research project. We establish how each selected activity contributes to the question, what the next stage requires, and how its results will be interpreted; you do not need to specify every technique before discussing a study.
Organoid Model Development Services
We plan model development around the tissue origin, experimental objective, and downstream sampling needs. Connecting construction with characterization and molecular profiling helps assess the features your study requires, rather than treating model growth alone as the endpoint.
Organoid Characterization Services
Morphology, selected tissue markers, and relevant molecular comparisons establish the evidence needed to assess model suitability. We connect these observations with the subsequent experimental design, so model characteristics inform which comparisons and sequencing readouts are appropriate.
Organoid Sequencing and Analysis Services
We align sequencing preparation and bioinformatics with the model, experimental conditions, and intended comparison. Sample-level expression, cell-level profiling, spatial analysis, or coding-region variant assessment becomes part of the study's evidence, with interpretation planned before data generation.
Organoid Drug Screening Services
Connect in vitro compound, concentration, or combination studies with expression profiling where molecular interpretation is required. We plan response measurements and sequencing samples together to investigate condition-associated pathways and identify questions for follow-up experiments.
Organoid Immune Cell Co-Culture Services
For studies of interactions absent from an epithelial model alone, we connect defined immune-cell co-culture with functional observations and suitable molecular profiling. This links the experimental system with evidence about which populations and expression states change under the study conditions.
Custom Epithelial Organoid Services
We align epithelial configurations, including polarity or organoid-derived monolayer formats, with questions about exposure orientation or barrier-related biology. Compatible molecular sampling is planned alongside the functional experiment, so culture format and sequencing preparation work toward the same objective.
Match Your Research Question to the Right Sequencing Readout
During project planning, we help determine whether your answer requires sample-level, cell-level, spatial, or genetic evidence. The assay is selected with the model, controls, and analysis in mind—not as an isolated technical purchase.
| Readout | Best for | Not for / when to choose another route |
|---|---|---|
| Bulk RNA sequencing | Comparing average expression and pathway-associated changes between conditions | Assigning a mixed-sample change to a specific cell type; consider cell-level profiling when that distinction matters |
| Single-cell or single-nucleus RNA sequencing | Examining cell composition, identity, and expression states | Directly retaining each cell's original tissue position; consider a compatible spatial assay for location-dependent questions |
| Spatial transcriptomics | Relating expression patterns to preserved tissue regions | Assuming every assay resolves individual cells or works with every preparation; choose the method around tissue and resolution needs |
| Whole exome sequencing | Comparing coding-region variants relevant to model characterization | Demonstrating complete genomic stability or full tissue equivalence; combine with other characterization appropriate to the question |
For condition-level expression comparisons, we can incorporate mRNA sequencing into the experimental plan. When cell composition may explain an apparent expression difference, single-cell RNA sequencing provides a cell-level perspective; sample condition informs whether a whole-cell or nuclei-based route is appropriate.
Where tissue context matters, our spatial multi-omics services can be considered alongside preservation and section-allocation plans. A comparative study of sequencing-based spatial methods shows why assay selection must consider tissue compatibility and effective performance, not nominal resolution alone. [5]
For relevant genetic comparisons, we connect whole exome sequencing with the broader characterization question. Its coding-region evidence complements, rather than replaces, morphology, cell-identity assessment, and functional observations.
Discuss a coordinated sequencing plan: connect the methods above with your models, experimental controls, and required outputs.
Sample Planning That Connects Every Stage
We plan sample requirements across the agreed workflow, not just for the next assay. Model origin, culture stage, controls, and biological replication inform how material is allocated and preserved, helping identify incompatible preparation steps before samples are committed.
| Input state | Information to provide | Potential route | Confirm before submission |
|---|---|---|---|
| Tissue or living organoids | Origin, culture history, condition labels, available model assessment | Model development, characterization, or sequencing preparation | Feasibility, material allocation, handling and transport instructions |
| Prepared cells or nuclei | Preparation method, preservation state, available quality measurements | Compatible cell-level expression profiling | Assay-specific acceptance and whether preparation could bias recovered populations |
| Preserved organoid sections | Preservation method, section preparation, orientation and available images | Compatible spatial or histological analysis | Tissue integrity, platform compatibility and allocation of adjacent material |
| Extracted RNA or DNA | Extraction method, quantity, quality assessment and sample mapping | Compatible RNA sequencing or exome analysis | Input suitability and whether enough material remains for the agreed workflow |
| Existing sequencing data | File types, reference information, sample sheet and previous analysis | Reanalysis or compatible dataset integration | Data completeness, design limitations and the new comparison required |
Share the information above before collecting, fixing, dissociating, or shipping material. We use it to define project-specific preparation requirements and the transitions between model work and molecular analysis; a single input threshold cannot cover every model and assay.
Culture conditions can affect the populations a model contains, as illustrated by work comparing cerebral organoid differentiation approaches. [4] We incorporate culture batch and developmental-stage information into the analysis plan so these factors can be assessed when interpreting experimental differences.
From Study Design to Results: How We Run Your Project
CD Genomics coordinates the agreed experimental and analytical work as one research project. Each stage is planned around what the next stage needs, with sample relationships, quality checks, and the final biological comparison carried through the workflow.
- Define the study and its outputs. We translate your objective into a model strategy, experimental comparisons, sequencing approach, and analysis scope, with the intended results identified upfront.
- Prepare models and experimental samples. We coordinate the agreed model development, characterization, and assay work, reviewing sample suitability and allocation before downstream processing.
- Generate molecular profiles. We connect experimental conditions and sampling stages with assay-specific preparation, library checks, and sequencing, retaining the identifiers needed for comparison.
- Analyze and interpret in context. We evaluate data quality and study design before interpreting expression differences, cell populations, spatial patterns, or variants against the agreed research question.
- Deliver the study's evidence. We organize the agreed data, results, and method records around the experimental comparisons, explaining interpretation limits and questions that warrant further investigation.
The analysis scope is established at project design, so the data generated are suited to the intended comparison. It combines shared study documentation with the relevant assay outputs; expression matrices, cell annotations, spatial outputs, and variant files are included according to the agreed work, not automatically bundled into every project.
Where suitable data and design are available, reference-atlas comparison or cross-assay integration can extend the interpretation. Neural organoid atlas research illustrates the value of comparing model cell states with reference information, while also showing why model differences require interpretation. [1]
Connected Results for Your Next Research Decision
Your project's value lies in connecting the experimental observations with the molecular evidence. We organize the agreed outputs so your team can trace a result back to the model, condition, quality assessment, and analysis that produced it.
- Study context: sample and condition mapping, relevant model or assay observations, and method records establish what was compared.
- Molecular evidence: workflow-specific outputs may include expression matrices, cell annotations, spatial results, or variant comparisons, accompanied by relevant quality summaries.
- Biological interpretation: comparison results and visualizations show which findings address the original question and where uncertainty remains.
The illustrative panels below show complementary result types, not a requirement to perform every assay in one project.
Compare Expression Across Conditions
A condition-level expression view links the planned experimental groups with gene programs associated with a perturbation. We interpret these patterns alongside replication and quality information; the image below is an illustrative example, not experimental data.
Examine Cell Populations and States
Cell-level visualizations connect model populations with marker-expression evidence, helping distinguish composition-related differences from changes within a population. Annotation informs interpretation, but cluster position alone does not establish a developmental lineage.
Relate Expression to Tissue Regions
Spatial views relate molecular patterns to the model architecture preserved during sample preparation. These findings are interpreted at the resolution supported by the selected assay; the illustrative diagram is not a platform-performance result.
Plan your organoid study with CD Genomics. Share the question, starting material, and result you need; we will help define the connected experimental and analytical work to get there.
Organoid Research and Sequencing FAQs
Can you support a complete organoid research project?
Yes. We can coordinate study planning, model development and characterization, the agreed experimental assays, sequencing, and data interpretation within one project. The scope follows your research objective, with the required stages and their connections defined before work begins.
Do I need to choose the sequencing methods before approaching you?
No. Start with the question and available material; we help define the appropriate approach. Bulk expression can address condition-level changes, while cell-level profiling helps distinguish composition changes from expression changes within a population.
Can one organoid batch support several assays?
Potentially; we assess allocation across the planned assays before processing. Fixed sections, dissociated cells, nuclei, and extracted nucleic acids are not interchangeable inputs, so separate portions or parallel cultures may be needed.
Does sequencing alone establish that a model is suitable?
No single readout establishes every aspect of model suitability. We plan characterization around the genetic, cellular, structural, or functional features your experiment requires, recognizing that organoids do not automatically contain all original tissue components.
Can expression profiling help interpret a drug-screening result?
We can plan expression sampling alongside in vitro response measurements to investigate condition-associated molecular changes, an approach illustrated in glioblastoma-like organoid research. [3] These associations generate hypotheses; they do not by themselves prove a compound's mechanism.
How should biological replication and batch effects be handled?
We address replication and batch structure during study design and carry the relevant metadata into analysis. Technical wells do not automatically constitute independent biological replicates, and statistical adjustment cannot rescue every confounded design.
Can the project begin with existing organoids or sequencing data?
Yes, subject to reviewing model condition or data compatibility. We define the remaining work around your existing material and research objective; completed steps need not be repeated, although missing experimental information can limit the analysis available.
What information is needed to scope a project?
Share the research objective, starting material, available model information, and intended result. We use these to develop the connected study scope, including experimental comparisons, sample preparation, sequencing, and analysis; you do not need to arrive with a complete technical specification.
Case Study: Resolving Cell Identity in Developing Retinal Organoids
Source: Wahle and colleagues reported an independent retinal organoid study in Nature Biotechnology in 2023. This is external research, not a CD Genomics customer project. [2]
Background: Developing organoids contain changing cell populations; identifying them requires molecular evidence beyond overall appearance.
Methods: The researchers combined time-course single-cell RNA and chromatin-accessibility profiles, supported by joint measurements at selected stages, to investigate cell identities and gene-regulation programs.
Results: The analysis distinguished retinal cell classes and developmental states and linked expression patterns with candidate gene-regulation relationships. Figure 3 presents the sequencing-focused analyses; separate imaging approaches contributed spatial information in the wider study.
Conclusion: For project design, the study highlights the value of planning models, sampling stages, and molecular readouts together. It does not establish that an organoid reproduces every property of its source tissue.
References:
- He Z, et al. An integrated transcriptomic cell atlas of human neural organoids. Nature. 2024;635:690–698.
- Wahle P, et al. Multimodal spatiotemporal phenotyping of human retinal organoid development. Nature Biotechnology. 2023;41:1765–1775.
- Wang C, et al. A multidimensional atlas of human glioblastoma-like organoids reveals highly coordinated molecular networks and effective drugs. npj Precision Oncology. 2024;8:19.
- Rosebrock D, et al. Enhanced cortical neural stem cell identity through short SMAD and WNT inhibition in human cerebral organoids facilitates emergence of outer radial glial cells. Nature Cell Biology. 2022;24:981–995.
- You Y, et al. Systematic comparison of sequencing-based spatial transcriptomic methods. Nature Methods. 2024;21:1743–1754.